Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|May 12, 2015
Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the ElderlyAgnes Csanadi, Claudia Kayser, Marcel Donauer, et al.
Journal of Geriatric Oncology|November 2, 2022
Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON studyWolfgang M Brueckl, Martin Reck, Harald Schäfer, et al.
Transfusion|June 2, 2026
Performance evaluation of a CD34 expression assay by digital PCR in bone marrow harvest from healthy donorsMiguel Waterhouse, Anja Kaufmann, Martina David, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Afatinib as first-line treatment in patients with <i>EGFR</i>-mutated non-small cell lung cancer in routine clinical practiceWolfgang M Brückl, Martin Reck, Frank Griesinger, et al.
Diagnostics (Basel, Switzerland)|August 5, 2020
Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient ManagementJulius Wehrle, Ulrike Philipp, Martina Jolic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2023
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trialsIlinca Popp, Rianne D W Vaes, Lotte Wieten, et al.
Blood|March 12, 2020
Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiencyArianna Troilo, Claudia Wehr, Iga Janowska, et al.
JCI Insight|March 4, 2020
MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitorsDominik Marschner, Martina Falk, Nora Rebeka Javorniczky, et al.
Pathologie (Heidelberg, Germany)|June 27, 2025
[Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board]Elaine-Pashupati Dopfer, Matthias Fahrner, Johanna Thiery, et al.
Molecular Oncology|October 15, 2021
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancerSilvia Waldeck, Jan Mitschke, Sebastian Wiesemann, et al.
Pageof 3